669 related articles for article (PubMed ID: 15931650)
21. Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations.
Ercolino T; Becherini L; Valeri A; Maiello M; Gaglianò MS; Parenti G; Ramazzotti M; Piscitelli E; Simi L; Pinzani P; Nesi G; Degl'Innocenti D; Console N; Bergamini C; Mannelli M
Clin Endocrinol (Oxf); 2008 May; 68(5):762-8. PubMed ID: 18031321
[TBL] [Abstract][Full Text] [Related]
22. Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis.
Gnarra JR; Lerman MI; Zbar B; Linehan WM
Semin Oncol; 1995 Feb; 22(1):3-8. PubMed ID: 7855617
[TBL] [Abstract][Full Text] [Related]
23. [Von Hippel-Lindau disease and renal cancer: 10 years of genetic progress. GEFVHL (French-Speaking Study Group on von Hippel-Lindau disease)].
Richard S; Beroud C; Joly D; Chretien Y; Benoit G
Prog Urol; 1998 Jun; 8(3):330-9. PubMed ID: 9689663
[TBL] [Abstract][Full Text] [Related]
24. Genetic analysis of von Hippel-Lindau disease.
Nordstrom-O'Brien M; van der Luijt RB; van Rooijen E; van den Ouweland AM; Majoor-Krakauer DF; Lolkema MP; van Brussel A; Voest EE; Giles RH
Hum Mutat; 2010 May; 31(5):521-37. PubMed ID: 20151405
[TBL] [Abstract][Full Text] [Related]
25. Single case of renal cell carcinoma and endocrine pancreatic head cancer occurring with von Hippel-Lindau disease.
Osawa A; Sumiyama Y; Watanabe M; Tanaka H; Asai K; Enomoto T; Matsukiyo H; Kanai R; Takeuchi Y; Oharazeki T
J Hepatobiliary Pancreat Surg; 2006; 13(2):174-80. PubMed ID: 16547682
[TBL] [Abstract][Full Text] [Related]
26. [Familial and genetic study in a large Chinese kindred with von Hippel-Lindau disease and gene mutation analysis].
Zhang J; Huang YR; Wang JD; Fan XD
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):5-9. PubMed ID: 14767899
[TBL] [Abstract][Full Text] [Related]
27. Mutations of the VHL tumour suppressor gene in renal carcinoma.
Gnarra JR; Tory K; Weng Y; Schmidt L; Wei MH; Li H; Latif F; Liu S; Chen F; Duh FM
Nat Genet; 1994 May; 7(1):85-90. PubMed ID: 7915601
[TBL] [Abstract][Full Text] [Related]
28. Von Hippel-Lindau disease--a rare disease important to recognize.
Joerger M; Koeberle D; Neumann HP; Gillessen S
Onkologie; 2005 Mar; 28(3):159-63. PubMed ID: 15772467
[TBL] [Abstract][Full Text] [Related]
29. [From gene to disease; Von Hippel-Lindau disease].
Hes FJ; Los M; van der Luijt RB
Ned Tijdschr Geneeskd; 2002 Jul; 146(29):1364-7. PubMed ID: 12162174
[TBL] [Abstract][Full Text] [Related]
30. Chromosome 3p deletion in a renal cell carcinoma cell line established from a patient with von Hippel-Lindau disease.
Kohno T; Sekine T; Tobisu K; Oshimura M; Yokota J
Jpn J Clin Oncol; 1993 Aug; 23(4):226-31. PubMed ID: 8105119
[TBL] [Abstract][Full Text] [Related]
31. Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas.
Kenck C; Wilhelm M; Bugert P; Staehler G; Kovacs G
J Pathol; 1996 Jun; 179(2):157-61. PubMed ID: 8758207
[TBL] [Abstract][Full Text] [Related]
32. [Pheochromocytoma, first manifestation of Von Hippel-Lindau disease: a possibility to be considered].
Richard S; Resche F; Vermesse B; Fendler JP; Francillard M; Laroche F; Luton JP; Méry JP; Proye C; Redondo A
Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1153-6. PubMed ID: 1482250
[TBL] [Abstract][Full Text] [Related]
33. [Von Hippel-Lindau disease].
Los M; Links TP; Lenders JW; Voest EE
Ned Tijdschr Geneeskd; 2000 Mar; 144(11):497-501. PubMed ID: 10735133
[TBL] [Abstract][Full Text] [Related]
34. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].
Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B
Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987
[TBL] [Abstract][Full Text] [Related]
35. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
[TBL] [Abstract][Full Text] [Related]
36. Genetic study of a large Chinese kindred with von Hippel-Lindau disease.
Huang YR; Zhang J; Wang JD; Fan XD
Chin Med J (Engl); 2004 Apr; 117(4):552-7. PubMed ID: 15109448
[TBL] [Abstract][Full Text] [Related]
37. Screening for renal carcinoma associated mutations in the von Hippel-Lindau tumor suppressor gene by temperature gradient gel electrophoresis.
Wenzel M; Enczmann J; Uhrberg M; Hernández A; Wiese U; Ackermann R; Schmitz-Draeger B; Ebert T; Wernet P
Electrophoresis; 1997 Jan; 18(1):45-51. PubMed ID: 9059819
[TBL] [Abstract][Full Text] [Related]
38. [Von Hippel-Lindau disease and molecular genetic diagnosis].
Jensen AM; Bisgaard ML
Ugeskr Laeger; 1999 Feb; 161(7):959-61. PubMed ID: 10051806
[TBL] [Abstract][Full Text] [Related]
39. Molecular genetics of renal cell carcinoma.
Wagner JR; Linehan WM
Semin Urol Oncol; 1996 Nov; 14(4):244-9. PubMed ID: 8946625
[TBL] [Abstract][Full Text] [Related]
40. [Bilateral kidney cancer in a patient with Von Hippel-Lindau disease].
Conquy S; Steg A; Ferry M
Ann Urol (Paris); 1987; 21(5):350-2. PubMed ID: 3426162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
